Evidence supporting the use of: Chaga mushroom
For the health condition: Hepatitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Traditional
Rating (out of 5): 2

Chaga mushroom (Inonotus obliquus) has a long history of use in traditional medicine, particularly in Russia, Siberia, and some parts of Asia. Its use as a remedy for liver health, including hepatitis, is primarily rooted in traditional practices rather than strong scientific validation. Folk medicine has employed chaga as a tonic for general health and to support liver function, with anecdotal reports suggesting benefits in conditions like hepatitis. From a scientific perspective, there is some preliminary evidence that chaga contains bioactive compounds such as polysaccharides, betulinic acid, and polyphenols, which exhibit antioxidant and anti-inflammatory properties in laboratory studies. A few in vitro and animal studies have indicated that chaga extracts might help reduce oxidative stress and inflammation in the liver. However, robust clinical trials in humans with hepatitis are lacking. Most available evidence is indirect or based on studies involving liver injury models rather than hepatitis specifically. In summary, while chaga is traditionally used to support liver health and there is some promising preclinical data, scientific evidence directly supporting its efficacy for hepatitis in humans is limited and not definitive. Its use for this condition is best described as "traditional" with a low-to-moderate evidence rating.

More about chaga mushroom
More about Hepatitis